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Abstract (max 250 words) 19 
 Avian influenza viruses occasionally infect and adapt to mammals, including humans. 20 
Swine are often described as ‘mixing vessels’, being susceptible to both avian and human 21 
origin viruses, which allows the emergence of novel reassortants, such as the precursor to 22 
the 2009 H1N1 pandemic. ANP32 proteins are host factors that act as influenza virus 23 
polymerase cofactors. In this study we describe how swine ANP32A, uniquely among the 24 
mammalian ANP32 proteins tested, supports activity of avian origin influenza virus 25 
polymerases, and avian influenza virus replication. We further show that after the swine-26 
origin influenza virus emerged in humans and caused the 2009 pandemic it evolved 27 
polymerase gene mutations that enabled it to more efficiently use human ANP32 proteins. 28 
We map the enhanced pro-viral activity of swine ANP32A to a pair of amino acids, 106 and 29 
156, in the leucine-rich repeat and central domains and show these mutations enhance 30 
binding to influenza virus trimeric polymerase. These findings help elucidate the molecular 31 
basis for the ‘mixing vessel’ trait of swine and further our understanding of the evolution 32 
and ecology of viruses in this host. 33 
Importance (max 150 words) 34 
 Avian influenza viruses can jump from wild birds and poultry into mammalian species 35 
such as humans or swine, but only continue to transmit if they accumulate mammalian 36 
adapting mutations. Pigs appear uniquely susceptible to both avian and human strains of 37 
influenza and are often described as virus ‘mixing vessels’. In this study, we describe how a 38 
host factor responsible for regulating virus replication, ANP32A, is different between swine 39 
and humans. Swine ANP32A allows a greater range of influenza viruses, specifically those 40 
from birds, to replicate. It does this through binding the virus polymerase more tightly than 41 
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the human version of the protein. This work helps to explain the unique properties of swine 42 
as ‘mixing vessels’. 43 
Introduction 44 
Influenza A viruses continuously circulate in their natural reservoir of wild aquatic 45 
and sea birds. Occasionally, avian influenza viruses infect mammalian hosts, but these 46 
zoonotic viruses have to adapt for efficient replication and further transmission. This limits 47 
the emergence of novel endemic strains. Avian-origin, mammalian-adapted influenza 48 
viruses have been isolated from a range of mammalian species including humans, swine, 49 
horses, dogs, seals, and bats (1-6).  50 
One mammalian influenza host of significance are swine, which have been described 51 
as susceptible to viruses of both human- and avian-origin (6). It has been hypothesised that 52 
swine act as ‘mixing vessels’, allowing efficient gene transfer between avian- and 53 
mammalian-adapted viruses. This leads to reassortants, which are able to replicate in 54 
humans, but to which populations have no protective antibody responses, as best illustrated 55 
by the 2009 H1N1 pandemic (pH1N1) (7). The ability of pigs to act as ‘mixing vessels’ has 56 
generally been attributed to the diversity of sialic acids, the receptors for influenza, found in 57 
pigs that would enable co-infection of a single host by diverse influenza strains (8, 9). The 58 
husbandry of swine has also been hypothesised to play a role in this ‘mixing vessel’ trait; 59 
swine are often exposed to wild birds and it is likely their environments are often 60 
contaminated with wild bird droppings containing avian influenza viruses (10, 11). 61 
For an avian-origin influenza virus to efficiently infect and transmit between 62 
mammals several host barriers must be overcome. One major barrier is the weak activity of 63 
avian influenza virus polymerases in the mammalian cell (12, 13). The acidic, (leucine-rich) 64 
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nuclear phosphoproteins of 32 kilodaltons (ANP32) proteins are key host factors responsible 65 
for the restricted polymerase activity of avian influenza viruses in mammalian cells (14). 66 
ANP32 proteins possess an N-terminal domain composed of five leucine rich repeats (LRRs) 67 
and a C-terminal low complexity acidic region (LCAR) separated by a short region termed the 68 
‘central domain’. In birds and most mammals three ANP32 paralogues are found: ANP32A, 69 
ANP32B and ANP32E (15, 16). The roles of ANP32 proteins in cells are diverse and often 70 
redundant between the family members but include histone chaperoning, transcriptional 71 
regulation, regulation of nuclear export and apoptosis (16). In birds, such as chickens and 72 
ducks, an exon duplication allows for the expression of an alternatively spliced, longer 73 
isoform of ANP32A that effectively supports activity of polymerases of avian influenza 74 
viruses (14, 17). Mammals only express the shorter forms of ANP32 proteins which do not 75 
efficiently support avian polymerase unless the virus acquires adaptive mutations, 76 
particularly in the PB2 polymerase subunit, such as E627K (14). A further difference 77 
between the ANP32 proteins of different species is the level of redundancy in their ability to 78 
support influenza polymerase. In humans, two paralogues – ANP32A and ANP32B – are 79 
essential but redundant influenza polymerase cofactors (18, 19). In birds, only a single 80 
family member – ANP32A - supports influenza virus polymerase activity, as avian ANP32B 81 
proteins are not orthologous to mammalian ANP32B (15, 19, 20). In mice, only ANP32B can 82 
support influenza A polymerase activity (18, 19). Neither avian nor mammalian ANP32E 83 
proteins have been shown to support influenza polymerase activity (18-20). 84 
In this study, we investigated the ability of a variety of mammalian ANP32 proteins 85 
to support influenza virus polymerases derived from viruses isolated from a range of hosts. 86 
We find differences in pro-viral efficiency that do not always coincide with the natural virus-87 
host relationship: for example, human ANP32B is better able to support bat influenza 88 
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polymerases than either bat ANP32 protein. Conversely, we describe evidence of human 89 
ANP32 adaptation early during the emergence of the pH1N1 virus from pigs, and find that 90 
swine ANP32A is the most potent pro-viral mammalian ANP32 protein tested, supporting 91 
non-adapted avian virus polymerase activity and avian influenza virus replication 92 
significantly better than human ANP32A. This can be attributed to amino acid differences in 93 
the LRR4 and central domains that enhance the interaction between swine ANP32A and the 94 
influenza polymerase complex, suggesting a mechanism for this enhanced pro-viral activity. 95 
Our findings give support to the special status as potential ‘mixing vessels’ of swine in 96 
influenza evolution. 97 
Results 98 
Mammals naturally susceptible to influenza have two pro-viral ANP32 proteins. 99 
To investigate the ability of different mammalian ANP32A and ANP32B proteins to 100 
support influenza virus polymerase activity, several mammalian-origin influenza virus 101 
polymerase constellations were tested using an ANP32 reconstitution minigenome assay. A 102 
previously described human cell line with both ANP32A and ANP32B ablated (eHAP dKO 103 
(18)) was transfected with expression plasmids encoding ANP32A or ANP32B from chicken, 104 
human, swine, horse, dog, seal or bat, as well as the minimal set of influenza polymerase 105 
expression plasmids for PB2, PB1, PA and nucleoprotein (NP), to drive amplification and 106 
expression of a firefly-luciferase viral-like reporter RNA and a Renilla-luciferase expression 107 
plasmid as a transfection control. 108 
Initially, we tested a panel of polymerases derived from human, canine, equine and 109 
bat influenza viruses. In contrast to chicken ANP32B, which does not support influenza virus 110 
polymerase activity (15, 19, 20), chicken ANP32A and all mammalian ANP32A and ANP32B 111 
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proteins supported activity of the mammalian-origin viral polymerases to varying degrees 112 
(Fig. 1a). Among the mammalian ANP32 proteins tested, for most polymerases, swine 113 
ANP32A provided the strongest support of polymerase activity, whereas the ANP32B 114 
proteins from dog, seal and bat displayed the least efficient pro-viral activity, lower than 115 
those species’ respective ANP32A proteins. These trends could not be explained by 116 
differences in expression levels or nuclear localisation (Fig. 1b, c). The bat influenza 117 
polymerases, along with (human) influenza B polymerase showed a different pattern of 118 
ANP32 usage, being able to strongly utilise ANP32Bs from all mammalian species, 119 
particularly human ANP32B (Fig. 1a). There was no evidence that influenza viruses adapted 120 
to particular mammals had evolved to specifically use the corresponding ANP32 proteins. 121 
For example, dog ANP32A or ANP32B were not the most efficient cofactors for canine 122 
influenza virus polymerase and human ANP32B was better able to support the bat influenza 123 
polymerase than either of the bat ANP32 proteins. 124 
Swine ANP32A, but not other mammalian ANP32 proteins, can support the polymerase 125 
activity and virus replication of avian-origin influenza viruses 126 
We next tested the ANP32 preference of a human 2009 (swine-origin) pH1N1 and 127 
two polymerases from swine influenza isolates. Interestingly, these polymerases were 128 
robustly supported by chicken and swine ANP32A, but not other mammalian ANP32 129 
proteins, with the Eurasian avian-like polymerase from A/swine/England/453/2006 (H1N1; 130 
sw/453) showing the clearest effect (Fig. 2a). We went on to test a panel of avian-origin viral 131 
polymerases with no known mammalian polymerase adaptations, including 132 
A/duck/Bavaria/77(H1N1; Bav), thought to be an avian precursor of the Eurasian avian-like 133 
swine lineage (Fig. 2b)(5). For all the avian origin viral polymerases the stringent preference 134 
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for avian ANP32A to support polymerase activity was evident (co-expression of chicken 135 
ANP32A led to very strong polymerase activity). However, amongst all the mammalian 136 
ANP32 proteins tested, only swine ANP32A was able to significantly support avian influenza 137 
polymerase activity, though to a lesser degree than chicken ANP32A (Fig. 2b). This unique 138 
pro-viral effect of swine ANP32A on swine and avian-origin polymerases was maintained 139 
across a wide titration of plasmid doses (Fig. 2c).  140 
Furthermore, we tested the relative ability of human and swine cells to support 141 
replication of a non-adapted avian influenza virus. Isogenic recombinant 142 
A/turkey/England/50-92/1991(H5N1; 50-92) virus containing either wild-type PB2 (E627) or 143 
the mammalian adaptation PB2-E627K were used to infect wild type human eHAP and swine 144 
NPTr cells (Fig 3a). Although E627K significantly increased the virus replication in both cell 145 
lines, the magnitude of difference was less in the swine cells than the human cells at earlier 146 
time points (for example 17-fold vs 110x-fold at 12 hours post-infection). The less drastic 147 
reduction in replication of the virus with non-adapted avian origin polymerase compared 148 
with the adapted control in swine cells is consistent with the hypothesis that swine ANP32A 149 
can support replication of avian influenza viruses. 150 
To investigate whether this difference was indeed accounted for by differences in 151 
ANP32A proteins, chicken, swine, or human ANP32A were pre-expressed in eHAP dKO cells 152 
that were then infected with 50-92 wild type and E627K recombinant viruses (Fig. 3b). As 153 
shown previously, when empty vector was expressed no virus replication took place (18). 154 
For the mammalian adapted PB2-E627K virus it made little difference which ANP32A protein 155 
was expressed although a trend was seen for chicken ANP32A supporting higher titres than 156 
swine ANP32A, which, in turn, supported higher titres than human ANP32A. For the non-157 
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adapted PB2-E627 virus, however, a greater and significant difference was seen – chicken 158 
ANP32A clearly supported virus replication better than either mammalian ANP32A protein. 159 
Swine ANP32A supported replication of the avian influenza virus to a higher level than 160 
human ANP32A at all time points, and this difference was significant (P<0.05) at 24 hours 161 
post infection. Overall, this indicates that swine ANP32A is better able to both support avian 162 
influenza virus polymerase activity, as well as virus replication, than human ANP32A. 163 
The pH1N1 swine influenza virus polymerase, adapting to humans, evolved to better use 164 
human ANP32 proteins 165 
 In 2009 the swine-origin pH1N1 influenza virus adapted from pigs for transmission 166 
between humans causing an influenza pandemic (7). The pH1N1 polymerase genes were 167 
derived from a swine triple reassortant constellation in which PB2 and PA originally derived 168 
from avian influenza viruses in the mid-1990s (21). From 2009 to 2010 the virus continued 169 
to circulate and adapt to humans in the second and third pandemic waves (22). pH1N1 170 
viruses contain the PB2 polymerase adaptations T271A, G590S, and Q591R, which appear to 171 
compensate for the lack of E627K in enabling replication in mammalian cells and these 172 
amino acids did not change between the first and third waves of the pandemic (23). We 173 
previously showed that a single substitution in the PA subunit of the polymerase, N321K, 174 
contributed to increased polymerase activity of third-wave pH1N1 viruses in human cells 175 
(22). We hypothesised that this PA mutation might function by improving support for the 176 
emerging virus polymerase by the human ANP32 proteins. 177 
 We performed minigenome assays with a first-wave pandemic virus, 178 
A/England/195/2009(pH1N1; E195), and a third-wave pandemic virus 179 
A/England/687/2010(pH1N1; E687), which differ in PA at position 321. As shown before, PA 180 
 on A







321K enhances polymerase activity in general in both virus polymerase backgrounds in 181 
human eHAP cells, as well as swine NPTr cells (Fig. 4a). However, the boost is far greater in 182 
the human cells (~7-fold) than in the swine cells (~2-fold), implying this mutation may have 183 
arisen to overcome the greater restriction seen upon the jump into humans (22).  184 
We next tested the ability of human and swine ANP32 proteins to support the 185 
different pH1N1 polymerases in eHAP dKO cells. Polymerases containing PA-321N are more 186 
robustly enhanced by swine ANP32A (by around 3.5-fold compared to human ANP32A), as is 187 
typical of swine-origin polymerases (Fig. 4b). Swine ANP32A, however, gives a much more 188 
modest boost to polymerase activity compared to human ANP32A when 321K is present 189 
(<2-fold). This suggests the PA N321K adaptation was selected in these viruses to adapt to 190 
the more poorly supportive ANP32 proteins present in human cells. We could further show 191 
that endogenous swine ANP32A protein is predominantly localised in the nucleus in swine 192 
NPTr cells, consistent with our previous over-expression data (Fig. 4c). 193 
Differences in swine and human ANP32A pro-viral activity can be mapped to the LRR4 194 
and central region. 195 
We set out to identify the molecular basis for the unusually high activity of swine 196 
ANP32A in comparison with the other mammalian ANP32 proteins. An alignment of ANP32A 197 
primary sequences identified three amino acids outside the LCAR, that differed between 198 
swine ANP32A and the other mammalian orthologues. Using reciprocal mutant ANP32A 199 
proteins, the identity of amino acid position 156, naturally a serine in swine ANP32A but a 200 
proline in most other mammalian and all avian ANP32A proteins, was shown to have a 201 
major, reciprocal influence on activity (Fig. 5a). The amino acid at position 106 contributed 202 
to a lesser degree, with swine-like valine enhancing pro-viral activity over human-like 203 
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isoleucine when complementing the swine influenza polymerase constellation, though 204 
changes at this residue appeared to have more minor effects on proviral activity supporting 205 
the 50-92 and Bav avian virus polymerases. Position 228, localised nearby the C-terminal 206 
nuclear localisation signal of ANP32A, had no appreciable impact. In the background of 207 
human ANP32A, I106V generally gave between a 1.5- and 6-fold increase in polymerase 208 
activity while P156S gave between a 3- and 16-fold boost, depending on the polymerase 209 
constellation tested. The combined 106/156 mutant showed an additive effect implying 210 
these two residues are, together, responsible for the enhanced pro-viral activity of swine 211 
ANP32A (Fig. 5a,c). None of the mutations affected expression levels (Fig. 5b). Positions 106 212 
and 156 map to the LRR4 and central domains of ANP32 protein, respectively, proximal to 213 
the previously characterised LRR5 residues, 129/130, that are responsible for the lack of 214 
pro-viral activity of avian ANP32B proteins (Fig. 5c)(15, 19). This reinforces the concept that 215 
the LRR4/LRR5/central region of ANP32 proteins is essential to their pro-viral function. 216 
Indeed, we could show that introducing the mutation N129I into swine ANP32A abrogated 217 
its ability to support influenza polymerase activity (Fig. 5a). 218 
An increase in binding to the polymerase accounts for the enhanced pro-viral activity of 219 
swine ANP32A 220 
 Pro-viral ANP32 proteins from birds and mammals directly bind trimeric polymerase 221 
in the cell nucleus (17, 24, 25). Moreover, the inability of avian ANP32B to support influenza 222 
polymerase activity correlates with a lack of protein interaction conferred by amino acid 223 
differences at residues 129 and 130 (15). 224 
 To assess the strength of interaction between swine ANP32A protein and influenza 225 
polymerase, we used a split-luciferase assay, where the two halves of Gaussia luciferase are 226 
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fused onto PB1 and ANP32 protein (15, 25). As seen previously (25), the interaction 227 
between influenza virus polymerase and human ANP32A was weak but detectable above 228 
background (huA, Fig. 6a). Swine ANP32A interacted more strongly with both human-origin - 229 
E195 (pH1N1 2009) - and avian-origin - A/turkey/England/50-92/1991(H5N1) - influenza 230 
polymerases, although not as strongly as chicken ANP32A (Fig. 6a). Furthermore, the two 231 
residues identified as being responsible for strong pro-viral activity of swine ANP32A, at 232 
positions 106 and 156, enhanced polymerase binding by human ANP32A and the reciprocal 233 
mutations decrease the swine ANP32A interaction, implying the mode of action of these 234 
mutations is through enhancing swine ANP32A-polymerase interactions (Fig. 6a). It was also 235 
shown that N129I, the substitution naturally identified in chicken ANP32B and previously 236 
shown to abolish binding and activity in chicken and human ANP32 proteins (15, 19), 237 
showed a similar phenotype in swine ANP32A, abolishing detectable binding and activity 238 
(Fig. 6a,b). The ablations of the pro-viral activity of swine ANP32A and ANP32B by the 239 
substitution N129I was not explained by reductions in expression of these mutant proteins 240 
(Fig. 6b,c). 241 
Estimating the pro-viral activity of ANP32A proteins from other mammalian species  242 
 Based on the molecular markers described in this study it is possible to survey 243 
ANP32A proteins from all mammals to predict which other species may have highly 244 
influenza polymerase supportive proteins and therefore potential to act as mixing vessels 245 
for reassortment between avian and mammalian-adapted influenza viruses. 246 
 Very few mammals share the pro-viral marker, 156S, and the few that do mostly 247 
constitute species not yet described as hosts for influenza viruses (Fig. 6d). A notable 248 
exception is the pika which, in a similar manner to pigs, are known to often become infected 249 
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with avian influenza viruses with minimal mammalian adaptation (26-28). Pigs are currently 250 
the only known mammalian species with a publicly available ANP32A sequence that contain 251 
the secondary, minor pro-viral maker 106V. 252 
Discussion 253 
 In this study we describe the ability of different mammalian ANP32A and ANP32B 254 
proteins to support activity of influenza virus polymerases isolated from a variety of hosts. 255 
We found that swine ANP32A, uniquely among the ANP32 proteins, supports avian 256 
influenza virus polymerase activity and virus replication. Swine ANP32A does not harbour 257 
the avian-specific 33 amino acid duplication that enables the strong interaction and efficient 258 
support of polymerase activity of avian-origin viruses by avian ANP32A proteins (14). Thus, 259 
avian influenza viruses are restricted for replication in swine as we have previously shown, 260 
and mammalian-adapting mutations enhance their polymerase activity in pig cells (11). 261 
Nonetheless, this level of pro-viral activity associated with swine ANP32A, albeit weaker 262 
than avian ANP32As, may contribute to the role of swine as mixing vessels: non-adapted 263 
avian influenza viruses that infect pigs could replicate sufficiently to accumulate further 264 
mutations that allow for more efficient mammalian adaptation and/or reassortment, 265 
enabling virus to either become endemic in swine or to jump into other mammals, including 266 
humans.  267 
We map this strongly pro-viral polymerase phenotype to a pair of mutations which 268 
allow swine ANP32A to bind more strongly to influenza virus polymerase, potentially 269 
explaining the mechanism behind its enhanced pro-viral activity. These residues are only 270 
found in a handful of other mammals including pika. It is conceivable these residues are 271 
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located at a binding interface between polymerase and ANP32, but resolution of the 272 
structure of the host:virus complex will be required to confirm this hypothesis. 273 
A recent study from Zhang and colleagues independently corroborated the superior 274 
ability of swine ANP32A amongst mammalian ANP32 proteins to support avian influenza 275 
virus polymerase activity (29). Moreover, they also correlated this phenotype with amino 276 
acids at position 106 and 156 that increased the strength of interactions between the host 277 
factor and the viral polymerase complex. In their studies the interaction between ANP32 278 
proteins and viral polymerase was measured by co-immunoprecipitation, making it unlikely 279 
that the similar differences we measured using our quantitative split luciferase assay were 280 
due to re-orientation of the luciferase tags.  281 
 It has long been speculated that swine play a role as ‘mixing vessels’, by acting as 282 
host to both human- and avian-origin influenza viruses (30). This trait may be partially 283 
attributed to receptor patterns in swine allowing viruses that bind to both α2,3 linked (i.e. 284 
avian-like viruses) and α2,6 linked sialic acid (i.e. human-like) to replicate alongside each 285 
other (8, 9). However, replication of the avian-origin influenza virus genomes inside infected 286 
cells is also required to enhance the opportunity for further adaptation or reassortment. We 287 
previously developed a minigenome assay for assessing polymerase activity in swine cells 288 
and showed that avian virus polymerases were restricted and that restriction could be 289 
overcome by typical mutations known to adapt polymerase to human cells (11). Taken 290 
together the ability to enter swine cells without receptor switching changes in the 291 
haemagglutinin gene, along with a greater mutation landscape afforded in swine cells by the 292 
partially supportive pro-viral function of swine ANP32A may have an additive effect to allow 293 
swine to act an intermediate host for influenza viruses to adapt to mammals. Furthermore, 294 
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our work implies other mammals, such as the pika, could play a similar role which is of 295 
particular interest due to the pika’s natural habitat often overlapping with that of wild birds 296 
and its (somewhat swine-like) distribution of both α2,3 and α2,6-linked sialic acid receptors 297 
(31). 298 
Upon crossing into humans from swine, it is likely that viruses would be under 299 
selective pressure to adapt to human pro-viral factors, such as the ANP32 proteins. We use 300 
the example of a pair of first- and third-wave pandemic H1N1 influenza viruses isolated from 301 
clinical cases in 2009 and 2010 (22). The polymerase constellation of the 2009 pH1N1 virus 302 
contains PB2 and PA gene segments donated from avian sources to a swine virus in a triple 303 
reassortant constellation in the mid-1990s, then passed onto humans in 2009 (21). Although 304 
the first-wave viruses, derived directly from swine, can clearly replicate and transmit 305 
between humans, over time the PA substitution, N321K, was selected because it enabled 306 
more efficient activity of the viral polymerase in human cells. Our data suggests this is a 307 
direct adaptation to human ANP32 proteins. This again illustrates how swine have acted as a 308 
‘halfway house’ for the step-wise adaptation of genes originating in avian influenza viruses 309 
that have eventually become humanised. 310 
 Also of note, we show here that as for the human orthologues (18, 19), the ANP32A 311 
and B proteins of swine (as well as all other mammals tested here) are redundant in their 312 
ability to support the viral polymerase. We further show that the substitution N129I is able 313 
to partially or fully ablate the pro-viral activity of swine ANP32A and ANP32B. We suggest 314 
that the introduction of this substitution in both swine ANP32A and ANP32B by genome 315 
editing would be a feasible basis for generating influenza resistant, or resilient, pigs, in a 316 
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similar manner to that demonstrated for porcine respiratory and reproductive syndrome 317 
virus resistant pigs, and proposed for influenza resistant, or resilient, chickens (15, 32). 318 
To conclude, we hypothesise that the superior pro-viral function of swine ANP32A 319 
for supporting influenza replication may enable swine to act as intermediary hosts for avian 320 
influenza viruses, and also affect the way the viruses evolve as they pass from birds, through 321 
swine, and onto humans. This, in turn, may influence the ability of different swine influenza 322 
viruses to act as zoonotic agents or as potential pandemic viruses. 323 
Materials and methods 324 
Cells 325 
Human engineered-Haploid cells (eHAP; Horizon Discovery) and eHAP cells with 326 
ANP32A and ANP32B knocked out (dKO) by CRISPR-Cas9, as originally described in (18), 327 
were maintained in Iscove’s Modified Dulbecco’s Medium (IMDM; ThermoFisher) 328 
supplemented with 10% fetal bovine serum (FBS; Biosera), 1% non-essential amino acids 329 
(NEAA; Gibco) and 1% Penicillin-streptomycin (pen-strep; invitrogen). Human embryonic 330 
kidney (293Ts, ATCC), Newborn Pig Trachea cells (NPTr; ATCC), and Madin-Darby Canine 331 
Kidney cells (MDCK; ATCC) were maintained in Dulbecco’s Modified Eagle Medium (DMEM) 332 
supplemented with 10% FBS, 1% NEAA and 1% pen-strep. All cells were maintained at 37oC, 333 
5% CO2. 334 
ANP32 plasmids constructs 335 
Animal ANP32 constructs were codon optimised and synthesised by GeneArt 336 
(ThermoFisher). Sequences used were pig (Sus scrofa) ANP32B (XP_020922136.1), Horse 337 
(Equus caballus) ANP32A (XP_001495860.2) and ANP32B (XP_023485491.1), Dog (Canis 338 
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lupus familiaris) ANP32A (NP_001003013.2), Dingo (Canis lupus dingo) ANP32B 339 
(XP_025328134.1), Monk Seal (Neomonachus schauinslandi) ANP32A (XP_021549451.1) and 340 
ANP32B (XP_021546921.1), and Common Vampire Bat (Desmodus rotundus) ANP32A 341 
(XP_024423449.1) and ANP32B (XP_024415874.1). All isoforms were chosen based on their 342 
orthology and synteny to the known functional human isoforms. Species of origin were 343 
chosen due to being influenza hosts or the most-commonly related species to influenza 344 
hosts (in the case of Monk Seal which are closely related to Harbour Seal whereas common 345 
vampire bats belong to the same family as little yellow-shouldered and flat-faced bats). 346 
Dingo ANP32B was substituted for dog ANP32B as the equivalent isoform used for all other 347 
ANP32Bs is unannotated in the dog genome due to a gap in the scaffold.  All ANP32 348 
expression constructs included a C-terminal GSG-linker followed by a FLAG tag and a pair of 349 
stop codons. Overlap extension PCR was used to introduce mutations into the ANP32 350 
constructs which were then subcloned back into pCAGGS and confirmed by Sanger 351 
sequencing.  352 
Viral minigenome plasmid constructs 353 
Viruses and virus minigenome full strain names used through this study were 354 
A/Victoria/1975(H3N2; Victoria), A/England/195/2009(pH1N1; E195), 355 
A/England/687/2010(pH1N1; E687), A/Japan/WRAIR1059P/2008(H3N2; Japan), 356 
B/Florida/4/2006 (B/Florida), A/Anhui/2013(H7N9; Anhui), A/duck/Bavaria/1/1977(H1N1, 357 
Bavaria), A/turkey/England/50-92/1991(H5N1; 50-92), A/chicken/Pakistan/UDL-358 
01/2008(H9N2; UDL1/08), A/canine/New York/dog23/2009(H3N8; CIV H3N8), 359 
A/canine/Illinois/41915/2015(H3N2; CIV H3N2), A/equine/Richmond/1/2007(H3N8; 360 
Richmond), A/swine/England/453/2006(EAH1N1; sw/453), A/swine/Hubei/221/2016(H1N1; 361 
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Hubei), A/little yellow-shouldered bat/Guatemala/164/2009(H17N10; H17) and A/flat-faced 362 
bat/Peru/033/2010(H18N11; H18). Viral minigenome expression plasmids (for PB2, PB1, PA 363 
and NP) for H3N2 Victoria, H5N1 50-92, H1N1 E195, H1N1 E687 IBV Florida/06, H9N2 364 
UDL1/08 and H1N1 Bavaria have been previously described (11, 14, 22, 33). Viral 365 
minigenome plasmids for H1N1 swine/453, H3N2 Japan, H3N2 CIV, H3N8 CIV, Hubei and 366 
Richmond were subcloned from reverse genetics plasmids or cDNA into pCAGGS expression 367 
vectors using virus segment specific primers.  368 
pCAGGs minigenome reporters for H17N10 and H18N11 bat influenza viruses were a 369 
kind gift from Professor Martin Schwemmle, Universitätsklinikum Freiburg (34). pCAGGs 370 
minigenome reporters for H7N9 were a kind gift from Professor Munir Iqbal, The Pirbright 371 
Institute, UK. Reverse genetics plasmids for H3N8, Richmond were a kind gift from Adam 372 
Rash of the Animal Health Trust, Newmarket, UK. Reverse genetics plasmids for H3N2 CIV 373 
and H3N8 CIV were a kind gift from Dr. Colin Parrish of the Baker Institute for Animal Health, 374 
Cornell University (35, 36). Viral RNA from sw/453 was kindly provided by Dr. Sharon 375 
Brookes, Animal Plant and Health Agency, Weybridge, UK. 376 
Minigenome assay 377 
eHAP dKO cells were transfected in 24 well plates using lipofectamine® 3000 378 
(thermo fisher) with a mixture of plasmids; 100ng of pCAGGs ANP32/pCAGGs empty, 40ng 379 
of pCAGGs PB2, 40ng of pCAGGs PB1, 20ng of pCAGGs PA, 80ng of pCAGGs NP, 40ng of 380 
pCAGGs Renilla luciferase, 40ng of polI vRNA-Firefly luciferase. Transfections in wild-type 381 
eHap cells were performed similarly but without ANP32. Transfections in NPTr cells were 382 
carried out in 12 well plates using the same ratios above. 24 hours post-transfection cells 383 
were lysed with passive lysis buffer (Promega) and luciferase bio-luminescent signals were 384 
 on A







read on a FLUOstar Omega plate reader (BMG Labtech) using the Dual-Luciferase® Reporter 385 
Assay System (Promega). Firefly signal was divided by Renilla signal to give relative 386 
luminescence units (RLU). All assays were performed with 2 or 3 separate repeats on 387 
different days, representative experiments are shown. 388 
Viruses replication assays 389 
All virus replication assays were performed with recombinant viruses containing the 390 
HA, NA and M genes of A/Puerto Rico/8/1934(H1N1; PR8) and the remaining genes from 391 
the avian influenza virus 50-92 containing PB2 627 E (wild type) or K, as has been described 392 
previously (11). eHAP dKO cells pre-transfected 24 hours prior with 400ng of pCAGGs-393 
ANP32A (chicken, swine or human) or pCAGGs-empty, or wild type eHAP or NPTr cells were 394 
infected at a multiplicity of infection of 0.001 in 6 well plates. Virus growth media, either 395 
IMDM or DMEM (for eHAP cells and NPTr cells, respectively) was made from serum-free 396 
media containing 1 μg/ml of N-tosyl-L-phenylalanine chloromethyl ketone-treated trypsin 397 
(Worthington-Biochemical). Virus containing supernatants were collected at 12, 24, 48, 72 398 
hours post-inoculation and stored at -80oC. Titres were assessed by infectious plaques on 399 
MDCKs. All time points were taken in triplicate and all virus growth curves were performed 400 
at least twice with a representative repeat shown. 401 
Split Luciferase Assay 402 
Split luciferase assays were undertaken in 293Ts seeded in 24 well plates. 30ng each 403 
of PB2, PA, and PB1, with the N-terminus of Gaussia Luciferase (Gluc1) tagged to its C-404 
terminus after a GGSGG linker, were co-transfected using lipofectamine 3000 along with 405 
ANP32A, tagged with the C-terminus of Gaussia Luciferase (Gluc2) on its C-terminus (after a 406 
GGSGG linker). 24 hours later cells were lysed in 100µl of Renilla lysis buffer (Promega) and 407 
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Gaussia activity was measured using a Renilla luciferase kit (Promega) on a FLUOstar Omega 408 
plate reader (BMG Labtech). Normalised luminescence ratios (NLR) were calculated by 409 
dividing the values of the tagged PB1 and ANP32 wells by the sum of the control wells which 410 
contained 1) untagged PB1 and free Gluc1 and 2) untagged ANP32A and free Gluc2 as 411 
described elsewhere (15, 37). 412 
Western Blotting 413 
To confirm equivalent protein expressing during mini-genome assays transfected 414 
cells were lysed in RIPA buffer (150mM NaCl, 1% NP-40, 0.5% Sodium deoxycholate, 0.1% 415 
SDS, 50mM TRIS, pH 7.4) supplemented with an EDTA-free protease inhibitor cocktail tablet 416 
(Roche). 417 
Membranes were probed with mouse α-FLAG (F1804, Sigma), rabbit α-Vinculin 418 
(AB129002, Abcam), rabbit α-PB2 (GTX125926, GeneTex) and mouse α-NP ([C43] ab128193, 419 
Abcam). The following near infra-red (NIR) fluorescent secondary antibodies were used: 420 
IRDye® 680RD Goat Anti-Rabbit (IgG) secondary antibody (Ab216777, Abcam) and IRDye® 421 
800CW Goat Anti-Mouse (IgG) secondary antibody (Ab216772, Abcam). Western Blots were 422 
visualised using an Odyssey Imaging System (LI-COR Biosciences). 423 
Immunofluorescence 424 
For investigating localisation of exogenously expressed ANP32 proteins, eHAP ANP32 425 
dKO cells were cultured on 8 well chambered cover slips (Ibidi) and transfected with 125 ng 426 
of the indicated FLAG-tagged ANP32 protein. Cells were fixed in PBS, 4% paraformaldehyde 427 
24 hours post transfection, then permeabilised in PBS, 0.2% Triton X-100. Cells were blocked 428 
in PBS, 2% bovine serum albumin and 0.1% tween. FLAG-tagged ANP32 proteins were 429 
detected using mouse anti-FLAG M2 primary antibody (Sigma), followed by goat anti-mouse 430 
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Alexa Fluor 568 (Invitrogen). Nuclei were counterstained with DAPI. Images were obtained 431 
using a Zeiss Cell Observer widefield microscope with ZEN Blue software, using a Plan-432 
Apochromat 63x 1.40-numerical aperture oil objective (Zeiss) and processed using FIJI 433 
software (38). 434 
For investigating endogenous levels of ANP32A in swine cells, NPTr cells were 435 
cultured in Nunc 24 well tissue culture plates on cover slips (VWR) preincubated with 10% 436 
(v/v) collagen (Rat’s tail, Sigma-Aldrich) in PBS. Cells were fixed with PBS, 4% 437 
paraformaldehyde for 20 minutes at room temperature. Cells were permeabilized with PBS, 438 
1% Triton X-100 for 10 minutes, followed by 3 washes with PBS 0.1% Triton X-100 and 439 
blocking with PBS, 5% (w/v) skim milk powder for 1 hour at room temperature. ANP32A was 440 
detected using ab189110 (Abcam) incubated in PBS, 5% (w/v) skim milk powder overnight at 441 
4°C, followed by incubation with anti-rabbit AlexaFluor488 (ab150077, Abcam). Phalloidin 442 
was detected using an AlexaFluor647 conjugated antibody (ab176759, Abcam), incubated 443 
during the secondary antibody application step at 1:10,000. Nuclei were counterstained 444 
with DAPI (1:15,000, Thermo Fisher). Images were captured with a Leica DMLB fluorescence 445 
microscope using Micro-Manager software at 40x or 20x for DAPI and Phalloidin 446 
respectively. Images were processed using FIJI software.  447 
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Figure legends 579 
Figure 1 – Most common mammalian influenza hosts have two ANP32 proteins capable of 580 
supporting influenza polymerase. a) Minigenome assays performed in human eHAP dKO 581 
with ANP32 proteins from different avian or mammalian species co-transfected. Green bars 582 
indicate species the influenza virus polymerase was isolated from, orange bars indicate 583 
recent species the virus has jumped from. Data indicates triplicate repeats plotted as mean 584 
with standard deviation. Data for each polymerase normalised to chicken ANP32A. b) 585 
Western blot assay showing protein expression levels of FLAG-tagged ANP32 proteins, NP 586 
and PB2 during a minigenome assay. c) Immunofluorescence images showing nuclear 587 
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localisation of all FLAG-tagged ANP32 proteins (red) tested. Nuclei are stained with DAPI 588 
(blue). Abbreviations: ch – chicken, hu – human, sw – swine, eq – equine.  Statistical 589 
significance was determined by one-way ANOVA with multiple comparisons against empty 590 
vector or between ANP32 proteins from the same host. *, 0.05 ≥ P > 0.01; **, 0.01 ≥ P > 591 
0.001; ***, 0.001 ≥ P > 0.0001; ****, P ≤ 0.0001. 592 
 593 
Figure 2. swANP32A can support the activity of minimally mammalian-adapted or 594 
completely non-adapted polymerases. Minigenome assays of swine (a) and avian (b) 595 
polymerases performed in human eHAP dKO cells with ANP32 proteins from different avian 596 
or mammalian species co-transfected. Green bars indicate species the influenza virus 597 
polymerase was isolated from, orange bars indicate recent species the virus has jumped 598 
from. Data indicates triplicate repeats plotted as mean with standard deviation. Data for 599 
each polymerase normalised to chicken ANP32A. c) ANP32 protein titrations with three 600 
different virus polymerase constellations. ANP32 expression plasmids were diluted in a 601 
series of 3x dilutions starting with 100ng. Data indicates triplicate repeats plotted as mean 602 
with standard deviation. Statistical significance was determined by one-way ANOVA with 603 
multiple comparisons against empty vector. **, 0.01 ≥ P > 0.001; ***, 0.001 ≥ P > 0.0001; 604 
****, P ≤ 0.0001. 605 
 606 
Figure 3. Swine ANP32A can support avian influenza virus replication better than human 607 
ANP32A. Comparative growth kinetics of isogenic, recombinant avian influenza viruses 608 
(A/turkey/England/50-92/1991(H5N1)) PB2 627E (wild type) vs E627K in (a) wild-type 609 
human eHAP cells and swine NPTr cells and (b) eHAP dKO cells pre-expressing empty vector, 610 
chicken, swine or human ANP32A. Cells were infected at a multiplicity of infection (MOI) of 611 
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0.001. All time points taken in triplicate and mean viral titres determined by plaque assay in 612 
MDCK cells with standard deviation shown. Graph is representative data of at least two 613 
independent repeats showing the same trends. Statistical significance determined by 614 
multiple Student’s t-tests in panel (a) and one-way ANOVA with multiple comparisons in 615 
panel (b). Value shown on graph in panel (a) indicate fold-change in mean titres. Dotted lines 616 
on graphs indicate limits of detection. *, 0.05 ≥ P > 0.01; **, 0.01 ≥ P > 0.001; ***, 0.001 ≥ P 617 
> 0.0001; ****, P ≤ 0.0001. 618 
 619 
Figure 4. Third-wave pandemic H1N1 viruses adapt to human ANP32 proteins through the 620 
PA mutation N321K.  a) Minigenome assays of polymerases derived from first- and third-621 
wave pH1N1 viruses (E195 and E687, respectively) performed in wild-type human eHAP cells 622 
and swine NPTr cells. Data indicates triplicate repeats plotted as mean with standard 623 
deviation. Data normalised to E195 wild type.  b) Minigenome assays performed in human 624 
eHAP cells with ANP32A and ANP32B knocked out and complemented with ANP32 proteins 625 
from human or swine following co-transfection of expression plasmids. Data indicates 626 
triplicate repeats plotted as mean with standard deviation. Data normalised to E195 wt with 627 
chicken ANP32A. All experiments in parts a) and b) performed on two separate occasions 628 
with a representative repeat shown. c) Indirect immunofluorescence images showing 629 
endogenous nuclear localisation of swine ANP32A in swine NPTr cells. Statistical significance 630 
was determined by one-way ANOVA with multiple comparisons. ****, P ≤ 0.0001. 631 
 632 
Figure 5. The enhanced pro-viral activity of swine ANP32A maps to amino acids in LRR4 633 
and the central domain. a) Minigenome assays with polymerase constellations from a swine 634 
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or an avian influenza virus performed in human eHAP dKO cells with human/swine ANP32A 635 
reciprocal mutants expressed. Data indicates triplicate repeats plotted as mean with 636 
standard deviation repeated on two separate occasions with a representative repeat shown. 637 
Data normalised to each polymerase with swine ANP32A wild type.  b) Western blot analysis 638 
showing expression levels of human/swine ANP32A from minigenome assays. c) Crystal 639 
structure of ANP32A (PDBID: 2JE1) with residues found to affect pro-viral activity mapped 640 
(39). The unresolved, unstructured LCAR shown as a yellow line. Schematic made using 641 
PyMol (40). Statistical significance was determined by one-way ANOVA with multiple 642 
comparisons. *, 0.05 ≥ P > 0.01; ***, 0.001 ≥ P > 0.0001; ****, P ≤ 0.0001. 643 
 644 
Figure 6. Amino acid residues responsible for the enhanced support of polymerase activity 645 
of swine ANP32A also mediate increased binding to influenza trimeric polymerase. a) Split 646 
luciferase assays showing the relative binding of different ANP32 proteins to trimeric 647 
polymerase from human pH1N1 or avian H5N1 viruses. PB1 was tagged with the N-terminal 648 
part of Gaussia luciferase while ANP32 proteins were tagged with the C-terminal part. NLR, 649 
normalised luminescence ratio, calculated from the ratio between tagged and untagged 650 
ANP32/PB1 pairs. Assay performed in 293T cells. Data indicates triplicate repeats plotted as 651 
mean with standard deviation, repeated across two separate experiments with 652 
representative data shown. Statistical significance was determined by one-way ANOVA with 653 
multiple comparisons between the swA and huA wild-types and mutants. ***, 0.001 ≥ P > 654 
0.0001; ****, P ≤ 0.0001. b) Minigenome assays with reconstituted polymerases from 3 655 
different influenza viruses, performed in human eHAP cells with ANP32A and ANP32B 656 
knocked out and complemented with wild type swine ANP32A or B or N129I mutants 657 
thereof. Data indicates triplicate repeats plotted as mean with standard deviation, repeated 658 
 on A







across two separate experiments with representative data shown. Data normalised to each 659 
polymerase with wild type swine ANP32A. c) Western blot assay showing protein expression 660 
levels of FLAG-tagged swine ANP32 wild type or N129I proteins during a minigenome assay. 661 
d) Phylogenetic tree of mammalian ANP32A proteins. Species which contain the highly pro-662 
viral 156S shown in red, species with 156P shown in black. Phylogenetic trees made using 663 
the neighbour-joining method based on amino acid sequence. Statistical significance was 664 
determined by one-way ANOVA with multiple comparisons against empty vector. ****, P ≤ 665 
0.0001. 666 
 on A
















































pril 14, 2020 by guest
http://jvi.asm
.org/
D
ow
nloaded from
 
